Development and Validation of a Novel Functional Eye-Tracking Software Application for Cancer-related Cognitive Impairment (CRCI)
Recruiting
This study aims to develop and validate a sensitive and non-invasive eye-tracking software application.
Gender:
FEMALE
Ages:
18 years and above
Trial Updated:
10/17/2023
Locations: McGill University Health Center-Cedar Cancer Center, Montréal, Quebec
Conditions: Cancer-related Cognitive Impairment
Treatment of Complex Regional Pain Syndrome
Recruiting
This study will investigate the feasibility of using repetitive transcranial magnetic stimulation (rTMS) and a sensorimotor training task to treat symptoms of pain in patients with complex regional pain syndrome (CRPS). rTMS is a non-invasive technique that involves delivering magnetic pulses in rapid succession over the area of the brain that controls movement. The sensorimotor training task involves non-invasive nerve stimulation used to cue a participant to complete motor actions. The purpose... Read More
Gender:
ALL
Ages:
Between 18 years and 70 years
Trial Updated:
10/17/2023
Locations: St. Joseph's Healthcare Hamilton King Campus, Hamilton, Ontario
Conditions: Complex Regional Pain Syndrome
The Refreshing Older Adults' Driving Skills (ROADSkills) Program
Recruiting
Drivers aged 65+ depend on their car(s) to get to the places and see the people that are important to them. Losing a license in later life has been linked to higher rates of loneliness, depression, and even admission to long-term care; a fact that is particularly relevant when considering the impact of the COVID-19 pandemic. While drivers in this age group are among the safest on the road, they have one of the highest risks of collision when distance driven is considered and are more likely to b... Read More
Gender:
ALL
Ages:
Between 65 years and 79 years
Trial Updated:
10/17/2023
Locations: McMaster Automotive Resource Centre, Hamilton, Ontario
Conditions: Drive
Investigating Eye-Movement Biomarkers of Disease Severity and Cognition in Multiple Sclerosis
Recruiting
The overarching goal of this research protocol is to acquire eye-tracking, cognitive, and disease-severity metrics in multiple sclerosis (MS) patients to further build up a database of MS patients and train a machine learning classifying algorithms to identify which eye-tracking metrics-or combination thereof-can serve as reliable markers of MS disease severity and cognitive status.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
10/17/2023
Locations: Genge Partners, Inc., Montreal, Quebec
Conditions: Multiple Sclerosis
Testing a Novel Therapeutic Strategy for Comorbid Post-Traumatic Stress Disorder and Alcohol Use Disorder
Recruiting
This study evaluates the therapeutic tolerability of the use of Cognitive Processing Therapy (CPT) with propranolol in participants with Posttraumatic Stress Disorder (PTSD) and Alcohol Use Disorder (AUD). The investigators are planning to perform an initial proof -of- concept randomized, placebo- controlled trial evaluating propranolol in participants with PTSD and AUD starting CPT for 12 weeks with three post-treatment follow ups at week-16, week-20, and week-24. Participants with current dia... Read More
Gender:
ALL
Ages:
Between 18 years and 70 years
Trial Updated:
10/16/2023
Locations: CAMH, Toronto, Ontario
Conditions: Stress Disorders, Post-Traumatic, Alcohol Use Disorder
Cerebral Flow-metabolism Coupling During Adult Surgery
Recruiting
The brain is a highly active organ that requires a large blood flow to function properly. Normally, blood flow is tightly linked to the brain's energy demands. However, during surgery, anesthesia can affect this relationship in different ways. Some types of anesthesia can decrease blood flow to the brain, while others can increase it. Anesthesiologists need to be careful to maintain adequate blood flow to the brain during surgery, especially when blood pressure drops. Drugs may be used to increa... Read More
Gender:
ALL
Ages:
19 years and above
Trial Updated:
10/16/2023
Locations: London Health Sciences Centre, London, Ontario
Conditions: Anesthesia
Presynaptic Imaging in Major Depressive Episodes After COVID-19
Recruiting
The goal of this observational study focuses on understanding and addressing a subset of persistent neuropsychiatric symptoms occurring within 3 months after mild to moderate COVID-19 infection (COVID-DNP). COVID-DNP encompasses major depressive episodes (MDE) with or without additional neuropsychiatric symptoms.
Gender:
ALL
Ages:
Between 18 years and 75 years
Trial Updated:
10/15/2023
Locations: Centre for Addiction and Mental Health, Toronto, Ontario
Conditions: Long COVID, Major Depressive Disorder, Major Depressive Episode
Study of Niacin in Glioblastoma
Recruiting
This is a single institution Phase I-II study to evaluate the tolerability and Maximum Tolerated Dose (MTD) (Phase I) and efficacy (Phase II) of adding Niacin CRT™ to standard first line treatment (concurrent Radiation Therapy (RT) and Temozolomide (TMZ) following by monthly TMZ - AKA Stupp protocol) in patients with newly diagnosed glioblastoma isocitrate dehydrogenase (IDH) wild type.
Gender:
ALL
Ages:
Between 18 years and 75 years
Trial Updated:
10/13/2023
Locations: Tom Baker Cancer Centre, Calgary, Alberta
Conditions: Glioblastoma IDH (Isocitrate Dehydrogenase) Wildtype
Gene-STEPS: Shortening Time of Evaluation in Paediatric Epilepsy Services
Recruiting
Overall, this observational cohort study aims too: 1. Implement rapid trio WGS for all children presenting to our health systems with epilepsy onset under 12 months of age. 2. Utilize electronic healthcare records and research databases to unite phenotypic and genomic data and to create a "virtual" registry across all institutions that will promote ongoing discovery. 3. Assess the impact of early genetic diagnosis on epilepsy, developmental, and health economic outcomes through formal longitudi... Read More
Gender:
ALL
Ages:
12 months and below
Trial Updated:
10/11/2023
Locations: Boston Children's Hospital, Boston, Massachusetts +3 locations
Conditions: Epilepsy
Investigating LFP Correlates of TUS in Patients With Movement Disorders
Recruiting
Transcranial Ultrasound Stimulation (TUS) is an emerging non-invasive brain stimulation(NIBS) technique that can be used on both superficial and deep brain targets with a high spatial resolution as small as a few cubic millimeters. Neural correlates of TUS have yet been elucidated. To date, no intracranial recordings (i.e., local field potential \[LFP\]) have been captured during or after TUS in patients with movement disorders. In this study, we are aiming to profile basal ganglia LFP activity... Read More
Gender:
ALL
Ages:
18 years and above
Trial Updated:
10/06/2023
Locations: Toronto Western Hospital, Toronto, Ontario
Conditions: Parkinson Disease, Essential Tremor, Dystonia
Olfactory Performance in Culinary Arts Students
Recruiting
The COVID-19 pandemic brought impaired smell and taste to the forefront of international public awareness and clinical importance. Loss of smell can impair awareness of environmental hazards, alter appetite, and have negative effects on social behavior and well-being. Despite the significant functional impact associated with impaired olfaction, few effective treatments are available. Olfactory training (OT), the mainstay of treatment, is a self-administered therapy which involves a routine of re... Read More
Gender:
ALL
Ages:
18 years and above
Trial Updated:
10/04/2023
Locations: Fanshawe College, London, Ontario
Conditions: Loss of Smell, Olfactory Disorder
SPIN Self-Management Feasibility Trial With Progression to Full-scale Trial (SPIN-SELF)
Recruiting
The Scleroderma Patient-centered Intervention Network (SPIN) is an organization established by researchers, health care providers, and people living with scleroderma (systemic sclerosis; SSc) from Canada, the United States, Mexico, Australia, France, Spain, and the United Kingdom. The objectives of SPIN are (1) to assemble a large cohort of SSc patients who complete outcome assessments regularly in order to learn more about important problems faced by people living with SSc and (2) to develop an... Read More
Gender:
ALL
Ages:
18 years and above
Trial Updated:
10/03/2023
Locations: Jewish General Hospital, Montréal, Quebec
Conditions: Scleroderma, Systemic Sclerosis